HCA Healthcare, Inc. $HCA Shares Purchased by HighTower Advisors LLC

HighTower Advisors LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,390 shares of the company’s stock after acquiring an additional 4,987 shares during the quarter. HighTower Advisors LLC’s holdings in HCA Healthcare were worth $18,389,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare during the third quarter valued at about $26,000. Holos Integrated Wealth LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $29,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $31,000. JPL Wealth Management LLC purchased a new stake in HCA Healthcare in the third quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The firm has a market capitalization of $87.49 billion, a price-to-earnings ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18. The business’s 50 day moving average price is $465.16 and its 200-day moving average price is $483.61.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the business earned $6.45 EPS. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analyst Ratings Changes

A number of brokerages recently commented on HCA. Royal Bank Of Canada dropped their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Sanford C. Bernstein lowered their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 28th. Mizuho upped their price objective on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. JPMorgan Chase & Co. lowered their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Finally, Oppenheimer lowered their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.